Neurotrope, Inc. announced that it has hired Dr. Richard Scheyer as Vice President and Chief Medical Officer, Mr. Ira Weisberg as Vice President, Commercial Operations and Mr. David Crockford as Vice President, Regulatory Affairs. All three new executives will report to Dr. James New, the company's President and Chief Executive Officer. Dr. Richard Scheyer has 30 years of professional medical experience which includes over 16 years dedicated to clinical drug development.

Dr. Scheyer was most recently President of in vivo veritas. Before joining Daiichi Sankyo, Dr. Scheyer was Director of Clinical Pharmacology. Mr. Weisberg is an accomplished pharmaceuticals and biotech executive with over 35 years in business and corporate development experience managing companies, fund raising, product development, sales and distribution channels, compliance, regulatory, managed care, reimbursement systems, licensing, and other corporate and business development transactions in both the U.S. and international markets.

Mr. Crockford has more than 30 years of professional experience in the biotechnology and pharmaceutical industries.